AveGene tests are based on Liquid Biopsy using a blood sample (plasma). This method can identify somatic variants in circulating cell-free tumor DNA (ctDNA).
A safe, non-invasive, sensitive, and economical technique for examining circulating tumor DNA (ctDNA) from the plasma of customers or those who may have the disease is called a “liquid biopsy.”
Through the examination of ctDNA extracted from a patient’s blood, we are able to detect genetic changes in ctDNA that are clinically significant and correlate these changes with specific treatments and clinical studies.
Viruses are intracellular parasites that replicate using the cell's internal environment and organelles. During a viral infection of a cell, a viral particle (occasionally only a portion; always the viral genetic information) invades the cell, exposes the viral genetic information, and initiates the expression of this information.
Various viruses have various replication requirements, and their replication mechanisms are also distinct (for instance, DNA and RNA viruses exhibit the most striking differences). Regardless, viral genetic information and viral proteins are external molecules that can interact with both cellular proteins and the cellular genome. This interaction can have numerous effects, including the initiation of the malignant (cancer) transformation process.
Heavy metals have technically the same effect on human body. Knowing the body contamination / infection is essential in cancer disease prevention.
At AveGene, we have implemented and responsibly use artificial intelligence (AI) and machine learning (ML). Both significantly improve the efficiency and accuracy of our company’s processes, particularly when processing large amounts of data, identifying patterns, and providing valuable clinical insights."
Please check that you have obtained the appropriate Sample Collection and Transportation Kit(s) for the test(s) you ordered.
HPV sample collection and transportation Kit. Its is intended for collection and shipment of urine specimen. This test kit is only compatible with HPV tests for male and female.
The "AveGene (Full Blood) Non invasive prenatal test sample collection & transport kit" contains special vials with a solution that preserves blood for up to 30 days at room temperature. This kit is intended for venous blood collection at your nearest doctor's office or healthcare center. It also includes transport components into which you will package the blood after collection and send it to the nearest AveGene collection center. This kit is compatible only with Prenatal Screening, but soon it might be also compatible with Oncology screening program.
The examination offers a comprehensive understanding of the most common genetic deficiencies that could pose a threat to the health of your expectant child. This includes Down syndrome, the most common and well-known genetic syndrome, as well as a few other relatively uncommon but frequently more severe genetic abnormalities.
The "AveGene ct/cfDNA liquid biopsy somatic & germinal mutations sample collection & transport kit" contains special vials with a solution that preserves blood for up to 14 days at room temperature. This kit is intended for venous blood collection at your nearest doctor's office or healthcare center. It also includes transport components into which you will package the blood after collection and send it to the nearest AveGene collection center. This kit is compatible with all types of our screening oncological tests, hereditary cancer risk test, and heavy metals test. These tests can be freely combined from a single sample.
Learn more about cf/ctDNA Liquid biopsy.
This sample collection kit is fully compatible with following tests:
Qualitative in vitro screening test from urine detecting 14 high-risk (HR) HPV genotypes at clinically relevant Infection levels in general and vaccinated pupulation. As the most common sexually transmitted infection, HPV affects nearly 80% of people during their lives, often without showing symptoms. This screening test empowers you to understand your HPV status, enabling proactive health management and reducing the risk of serious health conditions.
Liquid biopsy screening test, designed to effectively and without intervention analyze blood samples to provide comprehensive tumor profiling, focusing on clinically relevant content. Cancer is one of the most leading cause of death in the world. Symptoms are often equivocal and can be easily overlooked. Increasing number of cancers can be treated but It is important to diagnose it at the earliest possible stage, while it increases the survival rate.
Sensitive liquid biopsy screening test, designed to effecitively and without intervention analyze blood samples. This test is focused on colorectal (CRC) and lung tumours. Lung and CRC belong to the most common cancers worldwide. Symptoms are often equivocal and can be easily overlooked. Increasing number of cancers can be treated but It is important to diagnose it at the earliest possible stage, while it increases the survival rate.
-
1You select and purchase the test(s) via distributor, pharmacy or directly from our web pages. Based on your selection you get the Sample Collection kit(s), one for each test. It includes unique Kit ID code, which you register at AveGene web pages under your account.
-
2Blood samples are taken at AveGene partners collection centers or at any medical provider practioner, who is authorised and able to draw a visual blood. You can ask at a hospital or at nearest plasma center. Urine for HPV tests can be drawn at home.
-
3Samples are sent to a national collection center or the AveGene central laboratory. There is a transportation kit inside the Sample collection kit. After being transported, the sample is checked for free DNA quality in the lab before submitted to analysis. You will be infomed about the status and acceptation date.
-
4Test results are delivered back to patient in a form of encoded PDF file. Technically, there is a Layperson report part for easy understanding by patient, and Medical Doctor report part as an aid to patient's Medical Doctor to decide on final diagnosis. Electronic results from sequencing are provided in a form of FastQ files.
-
5Patients are able to request an online consultation with one of our oncologists or geneticists for a more detailed explanation. It is strongly advised that the patient's physician be present during the call, or the contact may be conducted directly between the doctors to expedite the clarification of the findings.
Learn more about the reports and how it should be understood. Please keep in mind the results shall always be consulted with your Medical Doctor who knows your physical status. This screening program shall act as an early detection alert. We do not provide diagnostics!
